Supernus Pharmaceuticals, Inc. (SUPN)

53.99 -1.59 (-2.86%) USD  |  NASDAQ  |  Mar 05, 12:25
More

Supernus Pharmaceuticals Other Income and Expenses (Quarterly)

Other Income and Expenses (Quarterly) Chart

View Other Income and Expenses (Quarterly) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Other Income and Expenses (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Other Income and Expenses (Quarterly) Range, Past 5 Years

View Other Income and Expenses (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Other Income and Expenses (Quarterly) Benchmarks

View Other Income and Expenses (Quarterly) Benchmarks
Start Trial
Biogen, Inc. Upgrade
BridgeBio Pharma, Inc. Upgrade
Corcept Therapeutics, Inc. --
Catalyst Pharmaceuticals, Inc. Upgrade
Cytokinetics, Inc. Upgrade